Novo Nordisk: Tackling China's Obesity Challenge Through Chronic Disease Management and Innovative Drug Development
Novo Nordisk: Tackling China's Obesity Challenge Through Chronic Disease Management and Innovative Drug DevelopmentThe rising prevalence of obesity in China poses a significant challenge. Obesity has become a serious chronic disease, substantially increasing the risk of other chronic conditions such as diabetes and cardiovascular diseases...
Joint study of Fudan and WHO: the infection rate of chronic hepatitis B has declined in China in the past 50 years, and vaccination has been proved effective
On October 5, 2023, the Journal of Gastrointestinal Tract (Gut) published online the latest achievement of the Chen Xingdong Research Group of the Human Phenotype Group at Fudan University, titled "Changes in Epidemiological Characteristics of Chronic Hepatitis B Infection in China: A Big Data Analysis and Systematic Text Study of 3740 Studies and 231 million People". This study covered 3740 related studies, analyzed the chronic hepatitis B infection status of 230 million people in 31 provinces, municipalities, autonomous regions, Hong Kong and Taiwan in mainland China, and systematically described the epidemiological characteristics of chronic hepatitis B infection in China in the past 50 years...